MedPath

河北万岁药业有限公司

Ownership
-
Established
1998-05-04
Employees
-
Market Cap
-
Website
www.wansui.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

NMPA:58

Drug Approvals

Valsartan and Amlodipine Tablets(I)

Product Name
缬沙坦氨氯地平片(Ⅰ)
Approval Number
国药准字H20253793
Approval Date
Apr 1, 2025
NMPA

Tofacitinib Citrate Tablets

Product Name
枸橼酸托法替布片
Approval Number
国药准字H20244998
Approval Date
Sep 26, 2024
NMPA

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字H20244303
Approval Date
Jun 28, 2024
NMPA

鹿川活络胶囊

Approval Number
国药准字Z20090659
Approval Date
Nov 3, 2023
NMPA

Vildagliptin Tablets

Product Name
维格列汀片
Approval Number
国药准字H20233660
Approval Date
Jun 7, 2023
NMPA

Leflunomide Tablets

Product Name
关平
Approval Number
国药准字H20080054
Approval Date
Oct 27, 2022
NMPA

Lisinopril Tablets

Product Name
赖诺普利片
Approval Number
国药准字H20113537
Approval Date
Jul 19, 2021
NMPA

龙胆泻肝丸

Approval Number
国药准字Z13020140
Approval Date
Aug 17, 2020
NMPA

当归拈痛丸

Approval Number
国药准字Z13020126
Approval Date
Aug 17, 2020
NMPA

复方板蓝根颗粒

Approval Number
国药准字Z13020139
Approval Date
Aug 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.